It has been four weeks since we started the process of bringing UF researchers back on campus through the UF Research Resumption Plan. I want to thank everyone for their incredible efforts. Research activities of over 4000 UF faculty, staff, post-docs and graduate students were successfully reviewed and approved though the Research Activity Approval Portal. These efforts to reengage activities that were disrupted due to the COVID-19 pandemic are remarkably important to the research mission and objectives of our enterprise. Again, thank you for your resiliency, patience, and dedication.
Beginning today, June 18 2020, we are progressing to Stage 3 of the resumption plan. For most activities, the significant change will be an increase in the allowed density of people per laboratory, an increase to 1 per 150 sq. ft. For human subject research, please see specific guidance at the Clinical and Translational Science Institutes’ page on resuming health-related human subjects research during COVID-19.
In order to assist researchers as we move to Stage 3 of the plan, we are providing the following guidance:
The COVID-19 Screen/Test process being administered by UF-HR / UF Health continues, and as a reminder, note that all UF employees must successfully complete this process before returning to UF facilities. After being cleared by UF-HR / UF Health, employees should coordinate with their department chair or facility administrator to establish a schedule for return.
As we progress through this stage, our success will remain dependent on our adherence to the UF Health Screen/Test/Protect program which include:
Together, we can accelerate the mission of UF research discovery that impacts our state, nation, and world.
David Norton, Vice President of Research, University of Florida.